Literature DB >> 2724427

Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings.

J Oldbring1, I Glifberg, P Mikulowski, S Hellsten.   

Abstract

We followed 657 primary bladder carcinoma patients for at least 10 years or until death. Subsequent carcinomas of the renal pelvis or ureter were found in 11 patients (1.7 per cent) 10 months to 13 years after the primary bladder tumor. In 3 patients the tumors were diagnosed or suspected by excretory urography, while in 5 the tumors were not found until autopsy. Four patients had undergone cystectomy and 9 had multiple bladder tumors at the initial assessment or during followup. The initial or recurrent bladder tumor involved the ipsilateral ureteral orifice in 6 patients. We conclude that in bladder cancer patients routine excretory urography is not indicated in the absence of upper urinary tract symptoms but it should be performed in selected patients, that is those with multiple and recurrent bladder tumors or tumors involving the ureteral orifices, or those with a previous cystectomy.

Entities:  

Mesh:

Year:  1989        PMID: 2724427     DOI: 10.1016/s0022-5347(17)41291-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.

Authors:  Enis Coskuner; Ibrahim Cevik; Alp Ozkan; Ozdal Dillioglugil; Atıf Akdas
Journal:  Int Urol Nephrol       Date:  2012-02-28       Impact factor: 2.370

2.  Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis.

Authors:  Laleh Ehsani; Adeboye O Osunkoya
Journal:  Tumour Biol       Date:  2014-05-30

3.  Ureteral involvement by metastatic malignant disease.

Authors:  Jieping Hu; Jun Deng; Ju Guo; Bin Fu
Journal:  Clin Exp Metastasis       Date:  2019-08-24       Impact factor: 5.150

Review 4.  Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.

Authors:  Julia V Fiuk; Brad F Schwartz
Journal:  World J Nephrol       Date:  2016-03-06

5.  Multidetector-row computed tomography (MDCT) in patients with a history of previous urothelial cancer or painless macroscopic haematuria.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse; Josef Hinterberger; Peter Schneede; Thomas Meindl; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 5.315

6.  Denovo urothelial carcinoma of the upper and lower urinary tract in kidney--transplant patients with end-stage analgesic nephropathy.

Authors:  W F Thon; V Kliem; M C Truss; P Anton; M Kuczyk; C G Stief; R Brunkhorst
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

7.  Single-session laparoscopic cystectomy and nephroureterectomy.

Authors:  Marcin Słojewski; Piotr Chłosta; Marek Myślak; Grzegorz Herlinger; Piotr Dobroński; Piotr Kryst; Tomasz Drewa
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-11-26       Impact factor: 1.195

8.  Monitoring of the upper urinary tract in patients with bladder cancer.

Authors:  Rajinikanth Ayyathurai; Mark S Soloway
Journal:  Indian J Urol       Date:  2011-04

9.  Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters.

Authors:  Serap Karaarslan; Banu Yaman; Hakan Ozturk; Banu Sarsik Kumbaraci
Journal:  J Pathol Transl Med       Date:  2015-09-16

10.  A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis.

Authors:  Chih-Ming Lu; Jen-Jie Lin; Han-Hsiang Huang; Ying-Chin Ko; Jue-Liang Hsu; Jiing-Chuan Chen; Zhong-Hao Din; Yu-Jen Wu
Journal:  BMC Cancer       Date:  2014-05-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.